Inventor · disambiguated record
Nicholas Giovannone
Also filed as: GIOVANNONE NICHOLAS
0 granted patents·4 pending applications·0 citations·filing 2025–2025
Files withREGENERON PHARMA4
Top patents by PatentIndex Score
4 records- 0148US2025276092A1Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody responseREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0247US2025242018A1Combination immunosuppression for inhibiting an immune response and enabling immunogen administration and re-administrationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0346US2025277048A1The use of cd40 inhibitors for inhibiting an immune response and enabling immunogen administration and re-administrationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0445US2025242056A1Methods and compositions for using plasma cell depleting agents and/or b cell depleting agents to suppress host anti-aav antibody response and enable aav transduction and re-dosingREGENERON PHARMA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Giovannone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →